GENEVA, SWITZERLAND – DITTA, the Global Diagnostic Imaging, Healthcare IT and Radiation Therapy Trade Association is, for the first time, attending the World Health Organization’s (WHO) Sixty-Eighth World Health Assembly (WHA) from 18-26 May 2015 since DITTA granted the status of NGO in official relationship with WHO.
Following on from the 2014 United Nations General Assembly, DITTA will be acknowledging the progress achieved by WHO in preventing and controlling non-communicable diseases (NCDs) at the WHA. DITTA is focused on working with WHO to achieve EU Member States’ health objectives on many health issues, including Millennium Development Goals and Sustainable Development Goals and NCDs.
NCDs caused 36 million deaths in 2008, accounting for more than three out of five deaths worldwide, and contributing towards half of global disability. NCDs also have a staggering economic impact – 50% of NCD-related deaths are during productive years, representing a significant cost to communities worldwide. With this in mind, DITTA has issued recommendations and a full statement on how to prevent and control NCDs, which can be found on its website.
At the WHA, DITTA is also supporting an event that will take place on 26 May on the following subject matter ‘Imaging for Saving Kids – the Inside Story about Patient Safety in Paediatric Radiology’, organized by the delegations of Kenya, Malaysia, Spain, Uganda including several highly recognized and respected international Medical and Scientific societies. This session will provide opportunities to openly discuss with policymakers, health care providers and patients organizations on how to appropriately use radiological procedures in paediatrics. While advanced imaging technology has opened up new horizons for children’s medical diagnosis, inappropriate use of radiation technology can lead to unnecessary radiation exposure with associated risks – and patient safety in paediatric imaging is of paramount importance.
Nicole Denjoy, DITTA Vice-Chair, said “I am delighted to lead DITTA’s delegation to the WHA. DITTA represents medical technology associations based in various geographies and brings its companies members together, sharing their knowledge and competences on highly innovative technologies contributing to saving lives and moving towards more sustainable healthcare systems around the globe. DITTA and its members fully support WHO’s plan to prevent and control NCDs, which pose the greatest health, economic and social risks globally. We believe early diagnosis will prevent the NCDs’ progression and improve patient prognosis. Additionally, DITTA believes radiotherapy is a clinically relevant and cost effective treatment modality playing a key role in an integrated cancer therapy program.”
This session brings together policymakers, health care providers and patients to discuss what can be done to improve health and service delivery when using radiation for medical imaging in children and how this can be achieved.
A DITTA Delegation, led by Nicole Denjoy, DITTA Vice-Chair, will participate this week at World health Assembly for the 1st time.
DITTA published a statement linked to item 13.4 on NCDs. Click here to access.
The official establishment of DITTA created one place for medical technology associations and companies around the globe to come together to discuss and promote efforts that will improve access to the life-saving technologies. DITTA is focused on working with WHO to achieve the Member States health objectives which include, communicable and non-communicable diseases, maternal, child and newborn health, health system strengthening, Millennium Development Goals and Sustainable Development Goals. Innovation in diagnostic imaging, radiotherapy and health ICT not only improves quality of life, but also increases better access to healthcare (reducing inequalities), reduces medical errors and enhances cost efficiency. The successful development and advancement of innovative medical technologies in the global marketplace promises to make available more innovative, life-saving technologies for countless patients around the world and to this end; DITTA wants to work in partnership with WHO and all stakeholders to achieve advancements and improvements in health for all. We believe early diagnosis may prevent the progression of Non Communicable Diseases and improve patient prognosis. Additionally; we believe radiotherapy is a clinically relevant and cost effective treatment modality playing a key role in an integrated cancer therapy program. Furthermore, investing in the whole care pathway from prevention to early diagnosis and effective treatment will achieve a return on output and save lives. Medical technologies are essential in the delivery of any healthcare system.